Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma

Moffitt, Richard A, Marayati, Raoud, Flate, Elizabeth L, Volmar, Keith E, Loeza, S Gabriela Herrera, Hoadley, Katherine A, Rashid, Naim U, Williams, Lindsay A +10 more·2015·Nature Genetics

DOI 10.1038/ng.3398

Cited by (1,002)

Items 101–200 of 1,002

Epigenetic plasticity cooperates with cell-cell interactions to direct pancreatic tumorigenesis
Cassandra Burdziak, Direna Alonso‐Curbelo, Thomas Walle, José Santos Reyes, Francisco M. Barriga, Doron Haviv, Yubin Xie, Zhen Zhao, Chujun Julia Zhao, Hsuan-An Chen et al. · 2023 · Science
Altered Gene Expression along the Glycolysis–Cholesterol Synthesis Axis Is Associated with Outcome in Pancreatic Cancer
Joanna M. Karasinska, James Thomas Topham, Steve E. Kalloger, Gun Ho Jang, Robert Edward Denroche, Luka Culibrk, Laura M. Williamson, Hui‐Li Wong, Michael K.C. Lee, Grainne Mary O'Kane et al. · 2019 · Clinical Cancer Research
The pancreatic cancer genome revisited
Hayashi, Akimasa, Hong, Jungeui, Iacobuzio-Donahue, Christine A. · 2021 · Nature Reviews Gastroenterology & Hepatology
DNA damage repair as a target in pancreatic cancer: state-of-the-art and future perspectives
Lukas Perkhofer, Johann Gout, Élodie Roger, Fernando Kude de Almeida, Carolina Simões, Lisa Wiesmüller, Thomas Theodor Werner Seufferlein, Alexander Kleger · 2020 · Gut
Cell-type deconvolution in epigenome-wide association studies: a review and recommendations
Andrew Erich Teschendorff, Shijie Zheng · 2017 · Epigenomics
Context-Specific Determinants of the Immunosuppressive Tumor Microenvironment in Pancreatic Cancer
Chiara Falcomatà, Stefanie Bärthel, Günter Schneider, Roland Rad, Marc Schmidt‐Supprian, Dieter Saur · 2023 · Cancer Discovery
TGF-β Signaling in Liver, Pancreas, and Gastrointestinal Diseases and Cancer
Nancy R. Gough, Xiyan Xiang, Lopa Mishra · 2021 · Gastroenterology
Single cell transcriptomic analyses implicate an immunosuppressive tumor microenvironment in pancreatic cancer liver metastasis
Shu Zhang, Wen Fang, Siqi Zhou, Dongming Zhu, Ruidong Chen, Xin Gao, Zhuojin Li, Yao Shi Fu, Yixuan Zhang, Fa Yang et al. · 2023 · Nature Communications
Cell plasticity in epithelial homeostasis and tumorigenesis
Júlia Varga, Florian R. Greten · 2017 · Nature Cell Biology
A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinoma
Akimasa Hayashi, Jun Fan, Ruoyao Chen, Yu-Jui Ho, Alvin P. Makohon-Moore, Nicolas Lecomte, Yi Zhong, Jungeui Hong, Jinlong Huang, Hitomi Sakamoto et al. · 2020 · Nature Cancer
Cholesterol Pathway Inhibition Induces TGF-β Signaling to Promote Basal Differentiation in Pancreatic Cancer
Linara Gabitova-Cornell, Aizhan Surumbayeva, Suraj Peri, Janusz Franco‐Barraza, Diana Restifo, Nicole Weitz, Charline Ogier, Aaron R. Goldman, Tiffiney R. Hartman, Ralph Francescone et al. · 2020 · Cancer Cell
Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma
Rekin’s Janky, María Mercedes Binda, Joke Allemeersch, Anke Van den broeck, Olivier Govaere, Johannes V. Swinnen, Tania Roskams, Stein Aerts, Baki Topal · 2016 · BMC Cancer
Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures
Zhengyan Kan, Ying Ding, Jin-Ho Kim, Hae Hyun Jung, Woosung Chung, Samir Lal, Soonweng Cho, Julio Fernandez-Banet, Se Kyung Lee, Seok Won Kim et al. · 2018 · Nature Communications
Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts
Rémy Nicolle, Yuna Blum, Laëtitia Marisa, Céline Loncle, Odile Gayet, Vincent Moutardier, Olivıer Turrini, Marc F. Giovannini, Benjamin Bian, Martin Bigonnet et al. · 2017 · Cell Reports
The Immune Subtypes and Landscape of Squamous Cell Carcinoma
Bailiang Li, Yi Cui, Dhanya K. Nambiar, John B. Sunwoo, Ruijiang Li · 2019 · Clinical Cancer Research
Pancreatic cancer treatment: better, but a long way to go
Robert J. Torphy, Yuki Fujiwara, Richard David Schulick · 2020 · Surgery Today
Extracellular Matrices and Cancer-Associated Fibroblasts: Targets for Cancer Diagnosis and Therapy?
Ismahane Belhabib, Sonia Zaghdoudi, Claire Lac, Corinne Bousquet, Christine Jean · 2021 · Cancers
Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor
Kevin D. Freeman‐Cook, Robert L. Hoffman, Nichol L. G. Miller, Jonathan Almaden, John Chionis, Qin Zhang, Koleen J. Eisele, Chaoting Liu, Cathy Zhang, Nanni H. Huser et al. · 2021 · Cancer Cell
Hexokinase 2 promotes tumor growth and metastasis by regulating lactate production in pancreatic cancer
Marybeth Anderson, Raoud Marayati, Richard A. Moffitt, Jen Jen Yeh · 2016 · Oncotarget
The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer
Qiqing Sun, Bo Zhang, Qiangsheng Hu, Yi Qin, Wenyan Xu, Wensheng Liu, Xianjun Yu, Jin Xu · 2018 · Theranostics
Pathology of pancreatic cancer
Lena Häberle, Iréne Esposito · 2019 · Translational Gastroenterology and Hepatology
KRAS drives immune evasion in a genetic model of pancreatic cancer
Irene Ischenko, Stephen D’Amico, Manisha Rao, Jinyu Li, Michael J. Hayman, Scott Powers, Oleksi Petrenko, Nancy C. Reich · 2021 · Nature Communications
Immune Cell and Stromal Signature Associated With Progression-Free Survival of Patients With Resected Pancreatic Ductal Adenocarcinoma
Ujjwal Mukund Mahajan, E Langhoff, Elisabetta Goni, Eithne Costello, William Greenhalf, Christopher Michael Halloran, Steffen Ormanns, Stephan Krüger, Stefan Hubert Boeck, Silvia Ribback et al. · 2018 · Gastroenterology
Stratification of Pancreatic Ductal Adenocarcinoma: Combinatorial Genetic, Stromal, and Immunologic Markers
Erik S. Knudsen, Paris J. Vail, Uthra Balaji, Hoai Ngo, Ihab W. Botros, Vladimir Makarov, Nadeem Riaz, Vinod P. Balachandran, Steven D. Leach, Debrah M. Thompson et al. · 2017 · Clinical Cancer Research
Survival of pancreatic cancer cells lacking KRAS function
Muzumdar, Mandar Deepak, Chen, Pan-Yu, Dorans, Kimberly Judith, Chung, Katherine Minjee, Bhutkar, Arjun, Hong, Erin, Noll, Elisa M., Sprick, Martin R., Trumpp, Andreas, Jacks, Tyler · 2017 · Nature Communications
Molecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunities
Wei Wang, Raju Kandimalla, Hao Huang, Lina Zhu, Ying Li, Feng Gao, Ajay Goel, Xin Wang · 2018 · Seminars in Cancer Biology
Glutamine depletion regulates Slug to promote EMT and metastasis in pancreatic cancer
Recouvreux, Maria Victoria, Moldenhauer, Matthew R., Galenkamp, Koen M.O., Jung, Michael, James, Brian, Zhang, Yijuan, Lowy, Andrew, Bagchi, Anindya, Commisso, Cosimo · 2020 · Journal of Experimental Medicine
Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome
Yeon Hee Park, Samir Lal, Jeong Eon Lee, Yoon‐La Choi, Ji Wen, Sripad Ram, Ying Ding, Soo Hyun Lee, Eric L. Powell, Se Kyung Lee et al. · 2020 · Nature Communications
Tumor microbiome links cellular programs and immunity in pancreatic cancer
Ghaddar, Bassel, Biswas, Antara, Harris, Chris, Omary, M. Bishr, Carpizo, Darren R., Blaser, Martin J., De, Subhajyoti · 2022 · Cancer Cell
Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options
Derya Kabacaoğlu, Katrin J. Ciecielski, Dietrich Alexander Ruess, Hana Algül · 2018 · Frontiers in Immunology
Arginase 1 is a key driver of immune suppression in pancreatic cancer
Rosa Elena Menjivar, Zeribe C. Nwosu, Wenting Du, Katelyn L. Donahue, Hanna S. Hong, Carlos E. Espinoza, Kristee L. Brown, Ashley Velez-Delgado, Wei Yan, Fatima Lima et al. · 2023 · eLife
Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors
Magdolna Djurec, Osvaldo Graña‐Castro, Albert Lee, Kevin Troulé, Elisa Espinet, Lavinia Cabras, Carolina Navas, María Teresa Blasco, Laura Martín-Díaz, Miranda Burdiel et al. · 2018 · Proceedings of the National Academy of Sciences
Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA
Gulfem Dilek Guler, Yuhong Ning, Chin‐Jen Ku, Tierney C. Phillips, Erin McCarthy, Christopher K. Ellison, Anna Bergamaschi, François Collin, Paul Lloyd, Aaron Scott et al. · 2020 · Nature Communications
NF-κB regulates GDF-15 to suppress macrophage surveillance during early tumor development
Nivedita M. Ratnam, Jennifer M. Peterson, Erin E. Talbert, Katherine J. Ladner, Priyani V. Rajasekera, Carl Richard Schmidt, Mary E. Dillhoff, Benjamin J. Swanson, Ericka N. Haverick, Raleigh D. Kladney et al. · 2017 · Journal of Clinical Investigation
Review of applications of high-throughput sequencing in personalized medicine: barriers and facilitators of future progress in research and clinical application
Lightbody, Gaye, Haberland, Valeriia, Browne, Fiona, Taggart, Laura, Zheng, Huiru, Parkes, Eileen, Blayney, Jaine K · 2019 · Briefings in Bioinformatics
EGFR-Pak signaling selectively regulates glutamine deprivation-induced macropinocytosis
Lee, Szu-Wei, Zhang, Yijuan, Jung, Michael, Cruz, Nathalia, Alas, Basheer, Commisso, Cosimo · 2019 · Developmental Cell
An Empirical Approach Leveraging Tumorgrafts to Dissect the Tumor Microenvironment in Renal Cell Carcinoma Identifies Missing Link to Prognostic Inflammatory Factors
Tao Wang, Rong Lü, Payal Kapur, Bijay Shankar Jaiswal, Raquibul Hannan, Ze Zhang, Iván Pedrosa, Jason J. Luke, He Zhang, Leonard D. Goldstein et al. · 2018 · Cancer Discovery
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer
Xiaoyong Fu, Resel Pereira, Carmine De Angelis, Jamunarani Veeraraghavan, Sarmistha Nanda, Lanfang Qin, Maria Letizia Cataldo, Vidyalakshmi Sethunath, Sepideh Mehravaran, Carolina Gutiérrez et al. · 2019 · Proceedings of the National Academy of Sciences
Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer
Luisa F. Escobar‐Hoyos, Alex Penson, Ram Kannan, Hana Cho, Chun‐Hao Pan, Rohit Kumar Singh, Lisa Helene Apken, G. Aaron Hobbs, Renhe Luo, Nicolas Lecomte et al. · 2020 · Cancer Cell
Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer
Stephan B. Dreyer, Rosanna Upstill‐Goddard, Viola Paulus-Hock, Clara Paris, Eirini-Maria Lampraki, Eloise V. Dray, Bryan Serrels, Giuseppina Caligiuri, Selma Rebus, Dennis Plenker et al. · 2020 · Gastroenterology
Pancreatic Cancer Genomes: Implications for Clinical Management and Therapeutic Development
Stephan B. Dreyer, David Kuang-Fu Chang, Peter J. Bailey, Andrew Victor Biankin · 2017 · Clinical Cancer Research
Patient-specific modeling of stroma-mediated chemoresistance of pancreatic cancer using a three-dimensional organoid-fibroblast co-culture system
Sebastian Schuth, Solange Le Blanc, Teresa G. Krieger, Julia Jabs, Miriam Schenk, Nathalia A. Giese, Markus Wolfgang Büchler, Roland Eils, Christian Conrad, Oliver Strobel · 2022 · Journal of Experimental & Clinical Cancer Research
Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types
Katharine Yu, Bin Chen, Dvir Aran, Joseph K. Charalel, Christina S. F. Yau, Denise M. Wolf, Laura van ‘t Veer, Atul Janardhan Butte, Theodore C. Goldstein, Marina Sirota · 2019 · Nature Communications
NRG1 Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in KRAS Wild-Type Pancreatic Ductal Adenocarcinoma
Martin R. Jones, Laura Williamson, James Thomas Topham, Michael K.C. Lee, Angela Goytain, Julie Ho, Robert Edward Denroche, Gun-Ho Jang, Erin Pleasance, Yaoquing Shen et al. · 2019 · Clinical Cancer Research
New Treatment Strategies for Metastatic Pancreatic Ductal Adenocarcinoma
Ritu Singh, Eileen Mary O'Reilly · 2020 · Drugs
Cancer associated fibroblast FAK regulates malignant cell metabolism
Fevzi Demircioglu, Jun Wang, Juliana B. Candido, Ana S.H. Costa, Pedro Casado, Beatriz de Luxán‐Delgado, Louise E. Reynolds, Jesús Gómez-Escudero, Emma Newport, Vinothini Rajeeve et al. · 2020 · Nature Communications
Molecular subtyping of cancer: current status and moving toward clinical applications
Lan Zhao, Victor Ho-Fun Lee, Michael K. Ng, Hong Yan, Maarten F. Bijlsma · 2018 · Briefings in Bioinformatics
Carcinogenesis of Pancreatic Ductal Adenocarcinoma
Peter Störz, Howard C. Crawford · 2020 · Gastroenterology
Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications
Miguel A. Martín-Serrano, Benjamin Kepecs, Miguel Torres‐Martín, Emily R. Bramel, Philipp Konstantin Haber, Elliot Merritt, Alexander Rialdi, Nesteene Joy Param, Miho Maeda, Katherine E. Lindblad et al. · 2022 · Gut
NFκB in Pancreatic Stellate Cells Reduces Infiltration of Tumors by Cytotoxic T Cells and Killing of Cancer Cells, via Up-regulation of CXCL12
Bharti Garg, Bhuwan Giri, Shrey Modi, Vrishketan Sethi, Iris Castro, Oliver Umland, Yuguang J. Ban, Shweta Lavania, Rajinder Kumar Dawra, Sulagna Banerjee et al. · 2018 · Gastroenterology
The role of hypoxia in pancreatic cancer: a potential therapeutic target?
Mert Erkan, Metin Kurtoğlu, Jorg H. Kleeff · 2015 · Expert Review of Gastroenterology & Hepatology
Basal‐like and classical cells coexist in pancreatic cancer revealed by single‐cell analysis on biopsy‐derived pancreatic cancer organoids from the classical subtype
Natalia Anahi Juiz, Abdessamad El Kaoutari, Martin Bigonnet, Odile Gayet, Julie Roques, Rémy Nicolle, Juan Iovanna, Nelson Dusetti · 2020 · The FASEB Journal
Analysis of Donor Pancreata Defines the Transcriptomic Signature and Microenvironment of Early Neoplastic Lesions
Eileen S. Carpenter, Ahmed M. Elhossiny, Padma Kadiyala, Jay Li, Jake J. McGue, Brian D. Griffith, Yaqing Zhang, Jacob Edwards, Sarah Nelson, Fatima Lima et al. · 2023 · Cancer Discovery
Cell of origin affects tumour development and phenotype in pancreatic ductal adenocarcinoma
Lee, Alex Y L, Dubois, Claire L, Sarai, Karnjit, Zarei, Soheila, Schaeffer, David F, Sander, Maike, Kopp, Janel L · 2019 · Gut
Tumor microbiome contributes to an aggressive phenotype in the basal-like subtype of pancreatic cancer
Wei Guo, Yuchao Zhang, Shiwei Guo, Zi Mei, Huiping Liao, Hang Ying Dong, Kaichun Wu, Haocheng Ye, Yuhang Zhang, Yufei Zhu et al. · 2021 · Communications Biology
A Four-Chemokine Signature Is Associated with a T-cell–Inflamed Phenotype in Primary and Metastatic Pancreatic Cancer
Romero, Joan M., Grünwald, Barbara, Jang, Gun-Ho, Bavi, Prashant P., Jhaveri, Aaditeya, Masoomian, Mehdi, Fischer, Sandra E., Zhang, Amy, Denroche, Robert E., Lungu, Ilinca M. et al. · 2020 · Clinical Cancer Research
The PDAC extracellular matrix: a review of the ECM protein composition, tumor cell interaction, and therapeutic strategies
Perez, Vincent M., Kearney, Joseph F., Yeh, Jen Jen · 2021 · Frontiers in Oncology
Generation of an in vitro 3D PDAC stroma rich spheroid model
Matthew J. Ware, Vazrik Keshishian, Justin J. Law, Jason C. Ho, Carlos A. Favela, Paul C. T. Rees, Billie Smith, Mohammad Sayeeduddin, Rosa F. Hwang, Kimal Rajapakshe et al. · 2016 · Biomaterials
Schwann cells regulate tumor cells and cancer-associated fibroblasts in the pancreatic ductal adenocarcinoma microenvironment
Meilin Xue, Youwei Zhu, Yongsheng Jiang, Lijie Han, Minmin Shi, Rui Jun Su, Liwen Wang, Cheng Xiong, Chaofu Wang, Ting Wang et al. · 2023 · Nature Communications
circFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF/STAT3 axis
Chonghui Hu, Renpeng Xia, Xiang Zhang, Tingting Li, Yuancheng Ye, Guolin Li, Rihua He, Zhihua Li, Qing Lin, Shangyou Zheng et al. · 2022 · Molecular Cancer
Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix
Jiang, Honglin, Torphy, Robert J., Steiger, Katja, Hongo, Henry, Ritchie, Alexa J., Kriegsmann, Mark, Horst, David, Umetsu, Sarah E., Joseph, Nancy M., McGregor, Kimberly et al. · 2020 · Journal of Clinical Investigation
Artificial intelligence in early drug discovery enabling precision medicine
Fabio Boniolo, Emilio Dorigatti, Alexander J. Ohnmacht, Dieter Saur, Benjamin Schubert, Michael P. Menden · 2021 · Expert Opinion on Drug Discovery
Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment
Etienne D. Foucher, Clément Ghigo, Salem Chouaı̈b, Jérôme Galon, Juan Iovanna, Daniel Olive · 2018 · Frontiers in Immunology
Identification of a subset of immunosuppressive P2RX1-negative neutrophils in pancreatic cancer liver metastasis
Xu Wang, Li-Peng Hu, Weiting Qin, Qin Yang, Deyu Chen, Qing Li, Kaixia Zhou, Pei-Qi Huang, Chunjie Xu, Jun Li et al. · 2021 · Nature Communications
TIMP1 Triggers Neutrophil Extracellular Trap Formation in Pancreatic Cancer
Benjamin Schoeps, Celina Eckfeld, Olga Prokopchuk, Jan P. Böttcher, Daniel Häußler, Katja Steiger, İhsan Ekin Demir, Percy Alexander Knolle, Oliver Soehnlein, Dieter E. Jenne et al. · 2021 · Cancer Research
Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?
Elisabeth Heßmann, Steven A. Johnsen, Jens Thomas Siveke, Volker Ellenrieder · 2016 · Gut
Fibroblasts in Pancreatic Ductal Adenocarcinoma: Biological Mechanisms and Therapeutic Targets
Martin C. Whittle, Sunil R. Hingorani · 2019 · Gastroenterology
ISG15 and ISGylation is required for pancreatic cancer stem cell mitophagy and metabolic plasticity
Sonia Alcalá, Patricia Sancho, Paola Martinelli, Diego Navarro, Coral Pedrero, Laura Martín-Hijano, Sandra Valle, Julie Earl, Macarena Rodríguez‐Serrano, Laura Ruíz-Cañas et al. · 2020 · Nature Communications
The biological underpinnings of therapeutic resistance in pancreatic cancer
Gregory Lawrence Beatty, Gregor Werba, Costas Andreas Lyssiotis, Diane M. Simeone · 2021 · Genes & Development
Morphological classification of pancreatic ductal adenocarcinoma that predicts molecular subtypes and correlates with clinical outcome
Sangeetha N. Kalimuthu, Gavin W. Wilson, Robert C. Grant, Matthew Seto, Grainne Mary O'Kane, Rajkumar Vajpeyi, Faiyaz Notta, Steve Gallinger, Runjan Chetty · 2019 · Gut
DNMT1 as a therapeutic target in pancreatic cancer: mechanisms and clinical implications
Kah Keng Wong · 2020 · Cellular Oncology
Endoscopic ultrasonography‐guided biopsy using a Franseen needle design: Initial assessment
Ji Young Bang, Shantel Hébert‐Magee, Muhammad Khalid Hasan, Udayakumar Navaneethan, Robert H. Hawes, Shyam Varadarajulu · 2016 · Digestive Endoscopy
Epithelial to mesenchymal plasticity and differential response to therapies in pancreatic ductal adenocarcinoma
Porter, Rebecca L., Magnus, Neelima K. C., Thapar, Vishal, Morris, Robert, Szabolcs, Annamaria, Neyaz, Azfar, Kulkarni, Anupriya S., Tai, Eric, Chougule, Abhijit, Hillis, Alessandra et al. · 2019 · Proceedings of the National Academy of Sciences
Spatial transcriptomic analysis of primary and metastatic pancreatic cancers highlights tumor microenvironmental heterogeneity
Ateeq Muhammed Khaliq, Meenakshi Rajamohan, Omer Abdelaziz Mohammed Saeed, Kimia Mansouri, Asif Adil, Chi Zhang, Anita Ahmed Turk, Julienne L. Carstens, Michael Garrett House, Sikander Hayat et al. · 2024 · Nature Genetics
Surgical and molecular pathology of pancreatic neoplasms
Wenzel M. Hackeng, Ralph H. Hruban, G. Johan A. Offerhaus, Lodewijk A.A. Brosens · 2016 · Diagnostic Pathology
A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets
Dongyu Jia, Zhenqiu Liu, Nan Deng, Tuan Zea Tan, Ruby Yun‐Ju Huang, Barbie Taylor‐Harding, Dong‐Joo Cheon, Kate Lawrenson, Wolf Ruprecht Wiedemeyer, Ann E. Walts et al. · 2016 · Cancer Letters
Molecular subtypes in cancers of the gastrointestinal tract
Maarten F. Bijlsma, Anguraj Sadanandam, Patrick B. O. Tan, Louis Vermeulen · 2017 · Nature Reviews Gastroenterology & Hepatology
EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance
Loretah Chibaya, Katherine C. Murphy, Kelly D. DeMarco, Sneha Gopalan, Haibo Liu, Chaitanya Naimesh Parikh, Yvette Lopez-Diaz, Melissa Faulkner, Junhui Li, John P. Morris et al. · 2023 · Nature Cancer
Integrated single-cell and spatial transcriptomics uncover distinct cellular subtypes involved in neural invasion in pancreatic cancer
Minmin Chen, Qinhang Gao, Huiheng Ning, Kang Chen, Yang Gao, Min Yu, Chaoqun Liu, Wei Zhou, Jieying Pan, Lusheng Wei et al. · 2025 · Cancer Cell
Elucidation of tumor-stromal heterogeneity and the ligand-receptor interactome by single-cell transcriptomics in Real-world pancreatic cancer biopsies
Lee, Jaewon J., Bernard, Vincent, Semaan, Alexander, Monberg, Maria E., Huang, Jonathan, Stephens, Bret M., Lin, Daniel, Rajapakshe, Kimal I., Weston, Brian R., Bhutani, Manoop S. et al. · 2021 · Clinical Cancer Research
Machete identifies interferon-encompassing chromosome 9p21.3 deletions as mediators of immune evasion and metastasis
Barriga, Francisco M., Tsanov, Kaloyan M., Ho, Yu-Jui, Sohail, Noor, Zhang, Amy, Baslan, Timour, Wuest, Alexandra N., Del Priore, Isabella, Meškauskaitė, Brigita, Livshits, Geulah et al. · 2022 · Nature Cancer
Recent advances in organoid development and applications in disease modeling
Sanchita Rauth, Saswati Karmakar, Surinder K. Batra, Moorthy Palanimuthu Ponnusamy · 2021 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Organoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic Cancer
Joseph Elan Grossman, Lakshmi B. Muthuswamy, Ling Huang, Dipikaa Akshinthala, Sofia Perea, Raul S. González, Leo L. Tsai, Jonah Cohen, Bruno Bockorny, Andrea J. Bullock et al. · 2021 · Clinical Cancer Research
Single-cell analysis of patient-derived PDAC organoids reveals cell state heterogeneity and a conserved developmental hierarchy
Teresa G. Krieger, Solange Le Blanc, Julia Jabs, Foo Wei Ten, Naveed Ishaque, Katharina Jechow, Olivia Debnath, Carl-Stephan Leonhardt, Anamika Giri, Roland Eils et al. · 2021 · Nature Communications
Recent insights into the biology of pancreatic cancer
Wantong Yao, Anirban Maitra, Haoqiang Ying · 2020 · EBioMedicine
Intraductal Transplantation Models of Human Pancreatic Ductal Adenocarcinoma Reveal Progressive Transition of Molecular Subtypes
Koji Miyabayashi, Lindsey A. Baker, Astrid Deschênes, Benno Traub, Giuseppina Caligiuri, Dennis Plenker, Brinda Alagesan, Pascal Belleau, Siran Li, Jude Kendall et al. · 2020 · Cancer Discovery
Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers
Jeffrey A. Klomp, Jennifer E. Klomp, Clint A. Stalnecker, Kirsten L. Bryant, A. Cole Edwards, Kristina Drizyte‐Miller, Priya S. Hibshman, J. Nathaniel Diehl, Ye S. Lee, Alexis Jean Morales et al. · 2024 · Science
Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells
Elvira Pelosi, Germana Castelli, Ugo Testa · 2017 · Biomedicines
HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer
Holly Brunton, Giuseppina Caligiuri, Richard Cunningham, Rosanna Upstill‐Goddard, Ulla‐Maja Bailey, Ian Garner, Craig Nourse, Stephan B. Dreyer, Marc D. Jones, Kim Moran‐Jones et al. · 2020 · Cell Reports
Senescent Carcinoma-Associated Fibroblasts Upregulate IL8 to Enhance Prometastatic Phenotypes
Wang, Tao, Notta, Faiyaz, Navab, Roya, Joseph, Joella, Ibrahimov, Emin, Xu, Jing, Zhu, Chang-Qi, Borgida, Ayelet, Gallinger, Steven, Tsao, Ming-Sound · 2017 · Molecular Cancer Research
Defining the molecular pathology of pancreatic body and tail adenocarcinoma
Australian Pancreatic Cancer Genome Initiative, Stephan B. Dreyer, Nigel Balfour Jamieson, Rosanna Upstill‐Goddard, Peter J. Bailey, C. J. McKay, Andrew Victor Biankin, David Kuang-Fu Chang · 2018 · British journal of surgery
Glucose Metabolism in Pancreatic Cancer
Yan Liang, P. Shalem Raj, Wantong Yao, Haoqiang Ying · 2019 · Cancers
Aggressive PDACs Show Hypomethylation of Repetitive Elements and the Execution of an Intrinsic IFN Program Linked to a Ductal Cell of Origin
Elisa Espinet, Zuguang Gu, Charles David Imbusch, Nathalia A. Giese, Magdalena Büscher, Mariam Safavi, Silke Weisenburger, Corinna Klein, Vanessa Vogel, Mattia Falcone et al. · 2020 · Cancer Discovery
Immune therapies in pancreatic ductal adenocarcinoma: Where are we now?
Marc Hilmi, Laurent Bartholin, Cindy Neuzillet · 2018 · World Journal of Gastroenterology
Desmoplasia in pancreatic ductal adenocarcinoma: insight into pathological function and therapeutic potential
Andrew C. Cannon, Christopher M. Thompson, Bradley R. Hall, Maneesh Jain, Sushil Kumar K, Surinder K. Batra · 2018 · Genes & Cancer
The Evolutionary Origins of Recurrent Pancreatic Cancer
Hitomi Sakamoto, Marc A. Attiyeh, Jeffrey M. Gerold, Alvin P. Makohon-Moore, Akimasa Hayashi, Jungeui Hong, Rajya L. Kappagantula, Lance Zhang, Jerry P. Melchor, Johannes G. Reiter et al. · 2020 · Cancer Discovery
Emerging roles for the IL-6 family of cytokines in pancreatic cancer
Gemma van Duijneveldt, Michael D. W. Griffin, Tracy L. Putoczki · 2020 · Clinical Science
Cell of origin influences pancreatic cancer subtype
Flowers, Brittany M., Xu, Hang, Mulligan, Abigail S., Hanson, Kathryn J., Seoane, Jose A., Vogel, Hannes, Curtis, Christina, Wood, Laura D., Attardi, Laura D. · 2021 · Cancer Discovery
Patient-derived Organoid Pharmacotyping is a Clinically Tractable Strategy for Precision Medicine in Pancreatic Cancer
Toni T. Seppälä, Jacquelyn W. Zimmerman, Elisabetta Sereni, Dennis Plenker, Reecha Suri, Noah Rozich, Alex B. Blair, Dwayne L. Thomas, Jonathan A. Teinor, Ammar A. Javed et al. · 2020 · Annals of Surgery
Posttranscriptional Upregulation of IDH1 by HuR Establishes a Powerful Survival Phenotype in Pancreatic Cancer Cells
Mahsa Zarei, Shruti Lal, Seth J. Parker, Avinoam Nevler, Ali Vaziri Gohar, Katerina Dukleska, Nicole Caroline Mambelli-Lisboa, Cynthia Moffat, Fernando F. Blanco, Saswati N. Chand et al. · 2017 · Cancer Research